1. Baumann H, Gauldie J (1990) Regulation of hepatic acute phase protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7: 147–159
2. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O (1991) Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 164: 1038–1043
3. Bichler KH, Kleinknecht S, Strohmeier WL (1990) Immune status and immune therapy of renal cell carcinoma. Urol Int 45: 269–283
4. Blay JY, Favrot M, Negrier S, Combaret V, Chouaib S, Mercatello A, Kaemmerlen P, Franks CR, Phillips T (1990) Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor. Cancer Res 50: 2371–2374
5. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Revault AMA, Tourani JM, Moskovtchenko JF, Philip T, Favrot M (1992) Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52: 3317–3322